GLOSSARY

Glucosamine–Chondroitin Combination combines glucosamine and chondroitin, requiring evidence for the mixture rather than assuming the ingredients' claims add together.

Collagen and gelatin provide amino acids associated with connective-tissue proteins, but their composition differs from complete proteins used for muscle nutrition. Studies on connective-tissue markers, symptoms and rehabilitation outcomes answer different questions. Vitamin C supports normal collagen synthesis; adding it does not guarantee faster healing. Loading and rehabilitation remain central to tendon or ligament care. A collagen product should not be treated as an equivalent replacement for all essential-amino-acid needs or as proof that an injury can safely return to competition.

Protein quality reflects digestibility and the supply of indispensable amino acids. Whey, casein, milk, soy and other foods differ in composition and digestion patterns, but a faster blood amino-acid rise does not automatically establish a better long-term outcome. Plant-based diets can support recovery when protein amounts, sources and overall intake are well planned. Blending sources or adjusting portions may be useful; the comparison should consider the complete meal and daily diet rather than a single ingredient label.

Unfamiliar or demanding exercise can produce temporary soreness, reduced function and changes in muscle-damage markers. Delayed-onset soreness is not simply accumulated lactate. Creatine kinase and myoglobin vary greatly between individuals, and a single blood value does not independently quantify recovery or diagnose the reason for pain. Strength, movement, symptoms and the time course provide complementary information. Severe pain, marked weakness, swelling or dark urine require prompt medical assessment rather than treatment as ordinary soreness.

A credible supplement claim needs relevant controlled evidence, an appropriate comparison and a meaningful outcome. Randomization, placebo control and blinding reduce different sources of bias but do not guarantee a useful result. Sample size, uncertainty, training status, sex, diet and protocol affect interpretation. A pooled estimate is not a promise to every individual. Mechanistic plausibility, a changed biomarker, exercise capacity and actual competition performance are distinct levels of information that should not be treated as interchangeable.

For example, a tendon-related laboratory marker after a collagen intervention does not by itself show that an athlete is ready to compete after injury. Coordinate nutrition with a rehabilitation plan and assess function. Keep sufficient complete protein in the wider diet rather than replacing all recovery protein with a collagen product.

Supplement safety depends on ingredient, dose, duration, health status and other exposures. Natural origin does not guarantee safety, and absence of a reported adverse event in a small trial does not establish long-term safety. Medication interactions, pregnancy, age and kidney or liver disease can change the decision. Distinguish an event occurring during use from a causally established adverse effect. New or severe symptoms require stopping the suspect exposure and appropriate assessment rather than increasing the dose to overcome poor tolerance.

Label accuracy, ingredient identity, potency, contamination control and manufacturing traceability are separate aspects of quality. A proprietary blend may conceal the amount of each ingredient, preventing comparison with research. A certificate of analysis applies to specified tests and samples, not every possible hazard. Verify the exact product and batch in an independent certification program when relevant. Good manufacturing practice and third-party testing can reduce certain risks without proving efficacy or guaranteeing that every batch is free of prohibited substances.